Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases

Purpose: To understand the prognostic value of The Cancer Genome Atlas (TCGA) for uveal melanoma metastasis, using a simplified 4-category classification, based on tumor DNA. Methods: A retrospective cohort study of 1001 eyes with uveal melanoma at a single center, categorized according to TCGA as G...

Full description

Bibliographic Details
Main Authors: Carol L Shields, Eileen L Mayro, Zeynep Bas, Philip W Dockery, Antonio Yaghy, Sara E Lally, Arupa Ganguly, Jerry A Shields
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=7;spage=1839;epage=1845;aulast=Shields
_version_ 1818607639454547968
author Carol L Shields
Eileen L Mayro
Zeynep Bas
Philip W Dockery
Antonio Yaghy
Sara E Lally
Arupa Ganguly
Jerry A Shields
author_facet Carol L Shields
Eileen L Mayro
Zeynep Bas
Philip W Dockery
Antonio Yaghy
Sara E Lally
Arupa Ganguly
Jerry A Shields
author_sort Carol L Shields
collection DOAJ
description Purpose: To understand the prognostic value of The Cancer Genome Atlas (TCGA) for uveal melanoma metastasis, using a simplified 4-category classification, based on tumor DNA. Methods: A retrospective cohort study of 1001 eyes with uveal melanoma at a single center, categorized according to TCGA as Group A, B, C, or D (by fine-needle aspiration biopsy for DNA analysis), and treated with standard methods, was studied for melanoma-related metastasis at 5 and 10 years. Results: Of 1001 eyes with uveal melanoma, the TCGA categories included Group A (n = 486, 49%), B (n = 141, 14%), C (n = 260, 26%), and D (n = 114, 11%). By comparison, increasing category (A vs. B vs. C vs. D) was associated with features of older age at presentation (56.8 vs. 52.8 vs. 61.1 vs. 63.5 years, P < 0.001), less often visual acuity of 20/20–20/50 (80% vs. 67% vs. 70% vs. 65%, P = 0.001), tumor location further from the optic disc (P < 0.001) and foveola (P < 0.001), and greater median tumor basal diameter (10.0 vs. 13.0 vs. 14.0 vs. 16.0 mm, P < 0.001) and tumor thickness (3.5 vs. 5.2 vs. 6.0 vs. 7.1 mm, P < 0.001). The Kaplan–Meier (5-year/10-year) rate of metastasis was 4%/6% for Group A, 12%/20% for Group B, 33%/49% for Group C, and 60%/not available for Group D. Conclusion: A simplified 4-category classification of uveal melanoma using TCGA, based on tumor DNA, is highly predictive of risk for metastatic disease.
first_indexed 2024-12-16T14:29:57Z
format Article
id doaj.art-c85af9b60a6d4180903bb1f78a5a8119
institution Directory Open Access Journal
issn 0301-4738
1998-3689
language English
last_indexed 2024-12-16T14:29:57Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Ophthalmology
spelling doaj.art-c85af9b60a6d4180903bb1f78a5a81192022-12-21T22:28:16ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892021-01-016971839184510.4103/ijo.IJO_313_21Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 casesCarol L ShieldsEileen L MayroZeynep BasPhilip W DockeryAntonio YaghySara E LallyArupa GangulyJerry A ShieldsPurpose: To understand the prognostic value of The Cancer Genome Atlas (TCGA) for uveal melanoma metastasis, using a simplified 4-category classification, based on tumor DNA. Methods: A retrospective cohort study of 1001 eyes with uveal melanoma at a single center, categorized according to TCGA as Group A, B, C, or D (by fine-needle aspiration biopsy for DNA analysis), and treated with standard methods, was studied for melanoma-related metastasis at 5 and 10 years. Results: Of 1001 eyes with uveal melanoma, the TCGA categories included Group A (n = 486, 49%), B (n = 141, 14%), C (n = 260, 26%), and D (n = 114, 11%). By comparison, increasing category (A vs. B vs. C vs. D) was associated with features of older age at presentation (56.8 vs. 52.8 vs. 61.1 vs. 63.5 years, P < 0.001), less often visual acuity of 20/20–20/50 (80% vs. 67% vs. 70% vs. 65%, P = 0.001), tumor location further from the optic disc (P < 0.001) and foveola (P < 0.001), and greater median tumor basal diameter (10.0 vs. 13.0 vs. 14.0 vs. 16.0 mm, P < 0.001) and tumor thickness (3.5 vs. 5.2 vs. 6.0 vs. 7.1 mm, P < 0.001). The Kaplan–Meier (5-year/10-year) rate of metastasis was 4%/6% for Group A, 12%/20% for Group B, 33%/49% for Group C, and 60%/not available for Group D. Conclusion: A simplified 4-category classification of uveal melanoma using TCGA, based on tumor DNA, is highly predictive of risk for metastatic disease.http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=7;spage=1839;epage=1845;aulast=Shieldschoroidciliary bodycytogeneticsgeneticsmelanomaoutcomestcgathe cancer genome atlasuvea
spellingShingle Carol L Shields
Eileen L Mayro
Zeynep Bas
Philip W Dockery
Antonio Yaghy
Sara E Lally
Arupa Ganguly
Jerry A Shields
Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases
Indian Journal of Ophthalmology
choroid
ciliary body
cytogenetics
genetics
melanoma
outcomes
tcga
the cancer genome atlas
uvea
title Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases
title_full Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases
title_fullStr Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases
title_full_unstemmed Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases
title_short Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases
title_sort ten year outcomes of uveal melanoma based on the cancer genome atlas tcga classification in 1001 cases
topic choroid
ciliary body
cytogenetics
genetics
melanoma
outcomes
tcga
the cancer genome atlas
uvea
url http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=7;spage=1839;epage=1845;aulast=Shields
work_keys_str_mv AT carollshields tenyearoutcomesofuvealmelanomabasedonthecancergenomeatlastcgaclassificationin1001cases
AT eileenlmayro tenyearoutcomesofuvealmelanomabasedonthecancergenomeatlastcgaclassificationin1001cases
AT zeynepbas tenyearoutcomesofuvealmelanomabasedonthecancergenomeatlastcgaclassificationin1001cases
AT philipwdockery tenyearoutcomesofuvealmelanomabasedonthecancergenomeatlastcgaclassificationin1001cases
AT antonioyaghy tenyearoutcomesofuvealmelanomabasedonthecancergenomeatlastcgaclassificationin1001cases
AT saraelally tenyearoutcomesofuvealmelanomabasedonthecancergenomeatlastcgaclassificationin1001cases
AT arupaganguly tenyearoutcomesofuvealmelanomabasedonthecancergenomeatlastcgaclassificationin1001cases
AT jerryashields tenyearoutcomesofuvealmelanomabasedonthecancergenomeatlastcgaclassificationin1001cases